These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 2467247

  • 1. Preparation, characterization and properties of monoclonal antibodies against intact H-ras p21 proteins.
    Sorrentino V, Nebreda AR, Alonso T, Santos E.
    Oncogene; 1989 Feb; 4(2):215-22. PubMed ID: 2467247
    [Abstract] [Full Text] [Related]

  • 2. Comparative immunohistochemical reactivity of monoclonal and polyclonal antibodies to H-ras p21 in normal and neoplastic tissues of rodents and humans.
    Ward JM, Perantoni AO, Santos E.
    Oncogene; 1989 Feb; 4(2):203-13. PubMed ID: 2648257
    [Abstract] [Full Text] [Related]

  • 3. Characterization of monoclonal antibodies specific to the activated ras p21 with aspartic acid at position 13.
    La Vecchio JA, Hamer PJ, Ng SC, Trimpe KL, Carney WP.
    Oncogene; 1990 Aug; 5(8):1173-8. PubMed ID: 2202949
    [Abstract] [Full Text] [Related]

  • 4. Detection of transforming ras proteins containing leucine at position 61 by a new mouse monoclonal antibody, ras(53-69)Leu61.
    Bizub D, Fischberg-Bender E, Heimer EP, Felix A, Skalka AM.
    Cancer Res; 1989 Nov 15; 49(22):6425-31. PubMed ID: 2680065
    [Abstract] [Full Text] [Related]

  • 5. Characterization of monoclonal antibody R256, specific for activated ras p21 with arginine at 12, and analysis of breast carcinoma of v-Harvey-ras transgenic mouse.
    Pullano TG, Sinn E, Carney WP.
    Oncogene; 1989 Aug 15; 4(8):1003-8. PubMed ID: 2474786
    [Abstract] [Full Text] [Related]

  • 6. Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridization.
    Ohuchi N, Hand PH, Merlo G, Fujita J, Mariani-Costantini R, Thor A, Nose M, Callahan R, Schlom J.
    Cancer Res; 1987 Mar 01; 47(5):1413-20. PubMed ID: 2434216
    [Abstract] [Full Text] [Related]

  • 7. Monoclonal antibody highly sensitive for the detection of ras p21 in immunoblotting analysis.
    Kanai T, Hirohashi S, Noguchi M, Shimoyama Y, Shimosato Y, Noguchi S, Nishimura S, Abe O.
    Jpn J Cancer Res; 1987 Dec 01; 78(12):1314-8. PubMed ID: 3123435
    [Abstract] [Full Text] [Related]

  • 8. Presence and possible role of c-ras and nuclear (c-fos and c-jun) proto-oncogene products in preimplantation embryonic development in mice.
    Ahmad K, Naz RK.
    Mol Reprod Dev; 1993 Nov 01; 36(3):297-306. PubMed ID: 8286110
    [Abstract] [Full Text] [Related]

  • 9. Preparation and characterization of monoclonal antibodies specific for human transforming growth factor alpha.
    Sorvillo JM, McCormack ES, Yanez L, Valenzuela D, Reynolds FH.
    Oncogene; 1990 Mar 01; 5(3):377-86. PubMed ID: 1690379
    [Abstract] [Full Text] [Related]

  • 10. Activated Val-12 ras p21 in cell culture fluids and mouse plasma.
    Hamer PJ, La Vecchio J, Ng S, DeLellis R, Wolfe H, Carney WP.
    Oncogene; 1991 Sep 01; 6(9):1609-15. PubMed ID: 1923528
    [Abstract] [Full Text] [Related]

  • 11. A monoclonal antibody reactive with an activated ras protein expressing valine at position 12.
    Carney WP, Hamer P, Petit D, Wolfe H, Cooper G, Lefebvre M, Rabin H.
    J Cell Biochem; 1986 Sep 01; 32(3):207-14. PubMed ID: 3536974
    [Abstract] [Full Text] [Related]

  • 12. Similarity of expression of low molecular weight G proteins smg p21A and ras p21 in normal and malignant human tissues.
    Takayama K, Furukawa K, Abe K, Kawase Y, Mizoguchi A, Kikuchi A, Takai Y, Matsui Y, Teranishi Y, Nakayama E.
    Cancer Res; 1991 Apr 15; 51(8):2223-8. PubMed ID: 1901241
    [Abstract] [Full Text] [Related]

  • 13. Immunocytochemical localization of p21 ras gene product in human hepatoma cell lines and corresponding tumors in athymic mice.
    Matarazzo M, Faraggiana T, Donato MF, Paronetto F.
    J Exp Pathol; 1987 Apr 15; 3(3):305-15. PubMed ID: 2835467
    [Abstract] [Full Text] [Related]

  • 14. Antisera to the variable region of ras oncogene proteins, and specific detection of H-ras expression in an experimental model of chemical carcinogenesis.
    Bizub D, Heimer EP, Felix A, Chizzonite R, Wood A, Skalka AM, Slater D, Aldrich TH, Furth ME.
    Oncogene; 1987 May 15; 1(2):131-42. PubMed ID: 2449645
    [Abstract] [Full Text] [Related]

  • 15. Establishment of four mouse hybridoma cell lines producing monoclonal antibodies reactive with ras oncogene product p21.
    Kuzumaki N, Oda A, Yamagiwa S, Taniguchi N, Kobayashi H, Oikawa T.
    J Natl Cancer Inst; 1986 Dec 15; 77(6):1273-9. PubMed ID: 3540418
    [Abstract] [Full Text] [Related]

  • 16. [Preparation and characterization of monoclonal antibody against DR5].
    Bai HL, Zhao YP, Liu GC, Ma YF.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jul 15; 22(4):514-6, 520. PubMed ID: 16806020
    [Abstract] [Full Text] [Related]

  • 17. [Oncogene products as tumor markers].
    Shiku H.
    Gan To Kagaku Ryoho; 1987 Jun 15; 14(6 Pt 2):2212-7. PubMed ID: 3300559
    [Abstract] [Full Text] [Related]

  • 18. Production and characterization of monoclonal antibodies to Ha-ras and N-ras p21.
    Ng S, Conlon J, Lavecchio J, Hamer PJ, Pullano T, Carney WP.
    Hybridoma; 1991 Aug 15; 10(4):467-80. PubMed ID: 1937497
    [Abstract] [Full Text] [Related]

  • 19. Optimal preservation of p21 ras immunoreactivity and morphology in paraffin-embedded tissue.
    Going JJ, Williams AR, Wyllie AH, Anderson TJ, Piris J.
    J Pathol; 1988 Jul 15; 155(3):185-90. PubMed ID: 3045276
    [Abstract] [Full Text] [Related]

  • 20. [Immunohistochemical study of ras p21 expression in human gastric cancers and benign lesions].
    Nakajima K.
    Hokkaido Igaku Zasshi; 1987 Jul 15; 62(4):573-80. PubMed ID: 3315926
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.